McDowell SE, Mt-Isa S, Ashby D, Ferner RE. Where errors occur in the preparation and administration of intravenous medicines: a systematic review and Bayesian analysis. Qual Saf Health Care. 2010; 19: 341-5.
McDowell SE, Coleman JJ, Evans SJ, Gill PS, Ferner RE. Laboratory monitoring and adverse patient outcomes with antihypertensive therapy in primary care. Pharmacoepidemiol Drug Saf. 2010 May;19(5):482-9.
Cox AR, Anton C, McDowell SE, Marriott JF, Ferner RE. Correlates of spontaneous reporting of adverse drug reactions within primary care: the paradox of low prescribers who are high reporters. Br J Clin Pharmacol. 2010; 69: 529-34.
Kshirsagar N.A., Olsson S., Ferner R.E. Consideration of the desirable features and possible forms of practical indicators of the performance of pharmacovigilance centres. International Journal of Risk and Safety in Medicine 2010; 22: 59-66.
Coleman JJ, McDowell SE, Evans SJ, Gill PS, Ferner RE. Oversight: a retrospective study of biochemical monitoring in patients beginning antihypertensive drug treatment in primary care. Br J Clin Pharmacol. 2010; 70: 109-17.
Karthikeyan VJ, Ferner RE, Baghdadi S, Lane DA, Lip GY, Beevers DG. Are angiotensin-converting enzyme inhibitors and angiotensin receptor blockers safe in pregnancy: a report of ninety-one pregnancies. J Hypertens. 2011 Feb;29(2):396-9.
Bonnici K, Stanworth D, Simmonds MSJ, Mukherjee E, Ferner RE. Flowers of evil. Lancet 2010; 376: 1616
Ferner RE, Hughes DA, Aronson JK. NICE and new: appraising innovation. BMJ 2010; 340: b5493.